This is an observational study for adults with glioblastoma (GBM), a common and aggressive brain tumor. The study aims to gather detailed information from patients treated across various hospitals in Europe and the United States. Researchers will collect data on demographics, imaging results, molecular types of the tumor, clinical status, surgical approaches, and how patients are managed after surgery, including any complications. The goal is to better understand glioblastoma and identify the best surgical strategies for different patient groups. The study will track how long patients live (Overall Survival) and how long they live without the disease getting worse (Progression Free Survival) for five years.

Study design

This is a prospective, observational study involving about 100 adult patients with glioblastoma across multiple centers.

What's involved

You would undergo a thorough medical history and clinical exam, and your imaging studies would be assessed. You would be closely monitored after surgery until discharge.

Compensation

Not stated in the trial record.

Follow-up

Your overall survival and progression-free survival will be measured for five years.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.